Publication | Closed Access

Study on invasive aspergillosis using galactomannan enzyme immunoassay and determining antifungal drug susceptibility among hospitalized patients with hematologic malignancies or candidates for organ transplantation

Invasive AspergillosisAntifungal AgentAntifungal Drug SusceptibilityGalactomannan EnzymeAntifungal AgentsPathologyMedicineFungal Pathogen